Digital Library
Close Browse articles from a journal
     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             17 results found
no title author magazine year volume issue page(s) type
1 A comparison of ten-year cardiac risk estimates in schizophrenia patients from the CATIE study and matched controls Goff, Donald C.
2005
80 1 p. 45-53
9 p.
article
2 Antidepressants as add-on treatment to antipsychotics for people with schizophrenia and pronounced negative symptoms: A systematic review of randomized trials Rummel, Christine
2005
80 1 p. 85-97
13 p.
article
3 Clinical correlates of tardive dyskinesia in schizophrenia: Baseline data from the CATIE schizophrenia trial Miller, Del D.
2005
80 1 p. 33-43
11 p.
article
4 Corrigendum to “Public preferences for health states with schizophrenia and a mapping function to estimate utilities from positive and negative symptom scale scores” [Schizophrenia Research 71 (1) (2004) 155–165] Lenert, Leslie A.
2005
80 1 p. 135-136
2 p.
article
5 Decision-making capacity for research participation among individuals in the CATIE schizophrenia trial Stroup, Scott
2005
80 1 p. 1-8
8 p.
article
6 Determining the chronology and components of psychosis onset: The Nottingham Onset Schedule (NOS) Singh, Swaran P.
2005
80 1 p. 117-130
14 p.
article
7 Early warning signs of relapse following a first episode of psychosis Gleeson, John F.
2005
80 1 p. 107-111
5 p.
article
8 Editorial Board 2005
80 1 p. CO2-
1 p.
article
9 Effects of atypical and typical neuroleptics on anterior cingulate volume in schizophrenia McCormick, Laurie
2005
80 1 p. 73-84
12 p.
article
10 Increase in gray matter and decrease in white matter volumes in the cortex during treatment with atypical neuroleptics in schizophrenia Molina, Vicente
2005
80 1 p. 61-71
11 p.
article
11 Persistent psychoses in first episode patients Manchanda, Rahul
2005
80 1 p. 113-116
4 p.
article
12 Prevalence of the metabolic syndrome in patients with schizophrenia: Baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III McEvoy, Joseph P.
2005
80 1 p. 19-32
14 p.
article
13 Serum lipid profiles and schizophrenia: Effects of conventional or atypical antipsychotic drugs in Taiwan Huang, Tiao-Lai
2005
80 1 p. 55-59
5 p.
article
14 The CATIE schizophrenia effectiveness trial DeLisi, L.E.
2005
80 1 p. v-vi
nvt p.
article
15 The Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Schizophrenia Trial: Clinical comparison of subgroups with and without the metabolic syndrome Meyer, Jonathan M.
2005
80 1 p. 9-18
10 p.
article
16 The effect of neuroleptic treatments on executive function and symptomatology in schizophrenia: A 1-year follow up study Rémillard, Sophie
2005
80 1 p. 99-106
8 p.
article
17 Weight gain and lipid metabolic abnormalities induced by olanzapine in first-episode, drug-naïve patients with psychotic disorders Sengupta, Sarojini M.
2005
80 1 p. 131-133
3 p.
article
                             17 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands